Evidence map›Paper›PMID 28752374›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2017

Erratum to: Serelaxin in acute heart failure patients with and without atrial fibrillation: a secondary analysis of the RELAX-AHF trial.

Gerasimos Filippatos, Dimitrios Farmakis, Marco Metra, Gad Cotter, Beth A Davison, G Michael Felker, Barry H Greenberg, Tsushung A Hua, Peter S Pang, Piotr Ponikowski and 4 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Gerasimos FilippatosNational and Kapodistrian University of Athens, Medical School, Athens, Greece. geros@otenet.gr.
Dimitrios FarmakisNational and Kapodistrian University of Athens, Medical School, Athens, Greece.
Marco MetraUniversity of Brescia, Brescia, Italy.
Gad CotterMomentum Research Inc., Durham, NC, USA.
Beth A DavisonMomentum Research Inc., Durham, NC, USA.
G Michael FelkerDuke Clinical Research Institute, Durham, NC, USA.
Barry H GreenbergUniversity of California at San Diego, San Diego, CA, USA.
Tsushung A HuaNovartis Pharmaceuticals Corporation, New Hanover, NJ, USA.
Peter S PangIndiana University School of Medicine and Regenstrief Institute, Indianapolis, IN, USA.
Piotr PonikowskiClinical Military Hospital, Medical University, Wroclaw, Poland.
Min QianColumbia University, New York, NY, USA.
Thomas A SeverinNovartis Pharma AG, Basel, Switzerland.
Adriaan A VoorsUniversity of Groningen, Groningen, The Netherlands.
John R TeerlinkUniversity of California-San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID28752374
PMCPMC6828441

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.